Evaluation of nasal symptom questionnaire in subjects with allergic rhinitis;Evaluación de un cuestionario para la medición de síntomas nasales en sujetos con rinitis alérgica

Revista Alergia Mexico

Volumn 50, Issue 1, 2003, Pages 17-21

  Montaño Velázquez, Bertha Beatriz ^a   Renaud, Kathrine Jáuregui ^a,b   Campillo Navarrete, Manuel Ramón ^a   Mogica Martínez, María Dolores ^a   Hinojosa, Arturo Ruiz ^a   Ángeles, Martín Becerril ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b Hospital General del Centro Médico Nacional La Raza   (Mexico)

Author keywords

Allergic rhinitis; Nasal symptoms; Questionnaire; Validity

Indexed keywords

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; SCHOOL CHILD; SYMPTOM; VALIDITY; EVALUATION; FOLLOW UP; HAY FEVER; HOSPITALIZATION; MOUTH BREATHING; NOSE MUCOSA; NOSE OBSTRUCTION; PERENNIAL RHINITIS; PSYCHOLOGICAL ASPECT; SECRETION; SNEEZING;

FOLLOW-UP STUDIES; HUMANS; MOUTH BREATHING; NASAL MUCOSA; NASAL OBSTRUCTION; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SEVERITY OF ILLNESS INDEX; SNEEZING;

EID: 0042705051     PISSN: 00025151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Winther L, Moseholm L, et al. Bashophil histamine release, IgE, eosinophil counts, ECP and EPX are related to the severity of symptoms in seasonal allergic rhinitis. Allergy 1999;54:436-45.
2. Van Cauwenberge, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis. Allergy 2000;55:116-34.
3. Meltzer E, Nathan R, Selner J, Storms W. Quality of life and rhinitis symptoms: Results of a nation wide survey with the SF-36 and RPLP questionnaires. J Allergy Clin Immunol 1997;99:815-9.
4. Malone DC, Lawson KA, et al. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol 1997;99:22-7.
5. Bousquet J, Bullinger M, et al. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994;94:182-8.
6. Ellis AK, Rafeiro E, Day JH. Quality of life indices may be predictive of placebo and medication response to treatment for allergic rhinitis. Ann Allergy Asthma Immunol 2001;86:393-6.
7. Kremer B, Klimek L, Bullinger M, Mosges R. Generic or disease-specific quality of life scales to characterize health status in allergic rhinitis? Allergy 2001;56:957-63.
8. Juniper EF, Guyatt GH, Griffith LE, Ferrie PJ. Interpretation of rhinoconjunctivitis quality of life questionnaire data. J Allergy Clin Immunol 1996;98:843-5.
9. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the Mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 2000;30:132-40.
10. Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: Development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 1994;93:413-23.
11. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol 1999;104:364-9.
12. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991;21:77-83.
13. Lindberg S, Malm L. Comparison of allergic rhinitis and vasomotor rhinitis patients on the basis of a computer questionnaire. Allergy 1993;48:602-7.
14. Santilli J, Nathan R, Glassheim J, Rockwell W, Gold K. Validation of the Rhinitis Outcomes Questionnaire (ROQ). Ann Allergy Asthma Immunol 2001;86:222-5.
15. Revicki DA, Leidy NK, Brennan-Diemer F, Thompson C, Togias A. Development and preliminary validation of the multiattribute Rhinitis Symptom Utility Index. Qual Life Res 1998;7:693-702.
16. Rojas RE, Garfias BY, Jimenez MMC, et al. Cell surface markers in patients with allergic rhinitis versus Der p and Der f challenge. Rev Alerg Mex 2000;47:190-6.
17. Douglas SA, Marshall AH, Walshaw D, Robson AK, Wilson JA. The development of a General Nasal Patient Inventory. Clin Otolaryngol 2001;26:425-9.
18. González GJ, García RG, Ramírez M, Santoyo S, Sánchez G. Estudio comparativo sobre eficacia y seguridad de dos antihistamínicos de nueva generación asociados a pseudoefedrina en ninos con rinitis alérgica. Invest Med Int 1993;20:80-84.
19. Davila VJ, Sánchez GM. Evaluación terapéutica de un antihistamínico asociado a pseudoefedrina en nin̄os con rinitis alérgica perenne. Invest Med Int 1993;20:85-91.
20. Fregoso A. Loratadina/pseudoefedrina en rinitis alérgica. Alergia, Asma e Inmunol Ped 2001;10:6-11.
21. Bronsky E, Boggs P, Findlay S, et al. Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis. J Allergy Clin Immunol 1995;96:139-47.
22. Jordana G, Dolovich J, Briscoe MP, et al. Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97:588-95.
23. Ortolani C, Foresi A, Di Lorenzo G, et al. A double-blind, placebo-controlled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis. Allergy 1999;54:1173-80.
24. Fregoso A. Estudio abierto y retrospectivo para evaluar la eficacia y seguridad de la combinación loratadina/pseudoefedrina en solución, en población pediátrica de 2 a 8 años con rinitis alérgica. Alergia Asma e Immunol Ped 2001;10:6-11.
25. Tinkelman DG, Kemp J, Mitchell DQ, Galant SP. Treatment of seasonal allergic rhinitis in children with cetirizine or chlorpheniramine: a multicenter study. Pediatric Asthma Allergic Immunol 1996;10:9-17.
26. Andersson M, Svensson C, Persson C, Akerlund A, Greiff L. Dose-dependent effects of budesonide aqueous nasal spray on symptoms in a daily nasal allergen challenge model. Ann Allergy Asthma Immunol 2000;85:279-83.
27. Corren J, Harris AG, Aaronson D, Beaucher W, et al. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. J Allergy Clin Immunol 1997;100:781-8.
28. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;8:307-10.
29. nd ed. New York: McGraw-Hill, 1978.
30. McFadden EA, Gungor A, et al. Loratadine/pseudoephedrine for nasal symptoms in seasonal allergic rhinitis: a double-blind, placebo-controlled study. ENT 2000;79:254-67.
31. Walker FD, White PS. Sinus symptom scores: what is the range in healthy individuals? Clin Otolaryngol 2000;25:482-4.
32. Becerril AMH, Pérez LA, Azuara PE. Nasal allergenic provocation test. Rev Alerg Mex 2000;47:166-8.